Anatomy of the 23andMe Fall and Implications for Consumer Genomics

Anatomy of the 23andMe fall and implications for consumer genomics

23andMe’s bankruptcy serves as a moment of reflection for the direct-to-consumer (DTC) genomics industry. We analyzed 23andMe financial data and business practices to reveal the factors behind the fall of the company, once valued at US $6 billion and now being considered for acquisition by Regeneron for merely $250 million. Key challenges faced by 23andMe in monetizing its genomic data reveal that this information, at least in a typical DTC sett…

Exclusive: CWEB Analysts Weigh In on 23andMe Founder Anne Wojcicki’s Bold Bid to Reclaim Company with Fortune 500 Backing

Menlo Park, CA – June 10, 2025 (CWEB News) – In a stunning twist to the 23andMe bankruptcy saga, founder Anne Wojcicki is mounting a formidable comeback bid to reclaim the genetic testing pioneer she started in her sister’s garage—this time with the backing of a Fortune 500 giant. CWEB analysts suggest this surprise development […]